Opinion

Video

Real-World Outcomes in HER2-Positive NSCLC

Key Takeaways

  • Real-world outcomes for HER2-positive NSCLC differ from clinical trials due to diverse patient populations and treatment settings.
  • Clinical trials involve selected patients, while real-world settings include those with comorbidities and varying performance statuses.
SHOW MORE

Dr Heymach real-world outcomes versus clinical trials for HER2-positive NSCLC and the management of common adverse events associated with HER2-directed therapies.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Caroline Vovan
1 expert is featured in this series.
1 expert is featured in this series.
Dr María Díez Campelo
Dr Caroline Vovan
Guy Young, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo